BioSpace News Archive

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, announced its raised mid-term business targets for 2025.

The Cystic Fibrosis Foundation announced the initiation of the HERO-2: Home Reported Outcomes Study, a first-of-its-kind, at-home observational study that aims to characterize the range of outcomes people experience while using Trikafta®.

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting on June 2nd 2021, at eClinical & Clinical Data Management Innovation Conference.

The market is estimated to grow at a CAGR of 8.2% from 2020 to 2027.

The animal health market was valued at US$ 73,798.33 million in 2019 and is expected to grow at a CAGR of 6.3% from 2020 to 2027 to reach US$ 119,570.99 million by 2027.

Spectrum Spine, spinal device supplier and leader in the development of spinal surgical device inventions, announced that it has acquired a highly unique and proprietary surface technology for spinal trauma and has begun operations with the device.

Vaccination via HD-MAP induced enhanced T-cell and spike-specific antibody responses as compared to needle-and-syringe delivery of the same vaccine in an animal model Complete protection from COVID-19 disease by a single dose skin patch delivery using Vaxxas’ HD-MAP was demonstrated in a lethal challenge of the SARS-COV-2 virus in an animal model

KoKo, a developer of respiratory information systems software and medical devices, and EirMed today announced a joint manufacturing partnership.

Free resource from the National Comprehensive Cancer Network helps employers select health plans and provide services to improve employee outcomes and minimize disruptions from cancer diagnoses--now available at NCCN.org/employertoolkit.

Ashlee Burrows of Lincoln, Nebraska commended for going above and beyond to safely care for and build trusting relationships with patients at home